TrialESC heart failure2019

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.

Gerhard Pölzl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.